Research News
Share:
BySpondylitis Association of America

A Biosimilar Version of Enbrel Gains FDA Approval

The Food and Drug Administration (FDA) approved the biologic Erelzi, (etanercept-szzs) in late August for conditions including ankylosing spondylitis…

Read more
BySpondylitis Association of America

Genetics of Ankylosing Spondylitis

Ankylosing spondylitis (AS) is considered a complex genetic disease, as more than one gene is involved. We know the importance and weight the HLA-B27 gene…

Read more
BySpondylitis Association of America

Distinguishing Clinical Features in Psoriatic Arthritis

In this new video from MD Magazine, Philip J. Mease, MD –– a respected leader in the field –– outlines…

Read more
BySpondylitis Association of America

Classification of Spondyloarthritis

In this video from MD Magazine, Dr. Philip J. Mease, MD –– a respected leader in the field –– explains the most recent classification guidelines released by…

Read more
BySpondylitis Association of America

FDA Approves the First Biosimilar Medication for Ankylosing Spondylitis and…

On April 5th, 2016 the FDA approved Inflectra / CT-P13,…

Read more
BySpondylitis Association of America

FDA Advisory Committee Unanimously Recommends Approval of a Biosimilar Version…

The FDA Arthritis Advisory Committee voted unanimously on July 12th…

Read more
1 18 19 20 21 22 23